Skip to content

Acquisition of clinical parameter, time response data and body core temperature during active or passive warming and during the day of patients sufferring from cholinergic urticaria

Acquisition of clinical parameter, time response data and body core temperature during active or passive warming and during the day of patients sufferring from cholinergic urticaria

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00004277
Enrollment
50
Registered
2012-07-26
Start date
2012-09-03
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

L50.5

Interventions

Group 1: Body core temperture measurement during active and passive provocation and day activitiy in patients with cholinergic urticaria Group 2: Body core temperture measurement during active and pas

Sponsors

Charité Campus Charité Mitte
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Volonteers (male or female), between 18 and 70 years od age, smoker or non smoker, valid healthy insurance, written informed consent, suspected to suffer from cholinergic urticaria

Exclusion criteria

Exclusion criteria: no valid health insurance, participation in another running study, Patients suffering from other diseases, that prohibt study participation (e.g. allergy against sensor material)

Design outcomes

Primary

MeasureTime frame
Detection of the change in body core temperature with the double sensor that is needed to induce skin reaktions in the patients

Secondary

MeasureTime frame
Detection of the change in body core temperature with the double sensor that is needed to induce skin reaktions in the patients

Countries

Germany

Contacts

Public ContactMarcus Maurer

Charité Campus Charité Mitte

marcus.maurer@charite.de030-450518043

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 18, 2026